Evidence for lymphocyte chemotaxis toward monocytes during PHA-induced aggregation in vitro

D R Jackola1, J J O'Leary

  • 1Department of Biophysical Sciences, University of Minnesota, Minneapolis 55455.

Cell Biophysics
|February 1, 1992
PubMed

Insights

This study developed a new assay to measure how immune cells form groups. Results show lymphocytes move towards monocytes, suggesting monocytes release a substance that attracts lymphocytes.

Area of Science:

  • Immunology
  • Cell Biology
  • Biophysics

Background:

  • Multicellular aggregate formation is a key early event in immune cell interactions in vitro.
  • Understanding the kinetics of these interactions is crucial for studying immune responses.

Purpose of the Study:

  • To develop and validate a quantitative assay for measuring the kinetics of multicellular aggregate formation in heterotypic cell populations.
  • To investigate the spatial dynamics and movement patterns of human peripheral lymphocytes and monocytes during aggregate formation.

Main Methods:

  • Development of a quantitative assay measuring an aggregation index over time in undisturbed cell cultures.
  • Utilizing the aggregation index as an indirect enumeration of cells within aggregates.
  • Formulating a mathematical model to describe aggregate formation kinetics and comparing it with experimental data.

Main Results:

  • The developed assay successfully quantifies the time-dependent changes in multicellular aggregate formation.
  • Experimental data showed an increase in the aggregation index over time, indicating active cell movement and interaction.
  • Comparison with a mathematical model indicated that lymphocytes exhibit directed movement towards monocytes, not random movement.

Conclusions:

  • The assay provides a robust method for studying immune cell aggregation kinetics.
  • Lymphocyte aggregation around monocytes is driven by directed movement, suggesting chemoattraction.
  • Monocytes likely release chemoattractants that influence lymphocyte behavior during early immune interactions.